Cost-Effectiveness of Rapid Diagnostic Tests for Malaria Treatment
Author Information
Author(s): Zikusooka Charlotte M, McIntyre Diane, Barnes Karen I
Primary Institution: University of Cape Town
Hypothesis
Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests?
Conclusion
Using rapid diagnostic tests can save costs in malaria treatment, especially when targeting older patients and using specific treatment strategies.
Supporting Evidence
- Cost savings were observed when RDTs were used in cases with low to moderate malaria prevalence.
- Targeting RDTs at patients older than six years was found to be more cost-effective.
- The study analyzed various scenarios of malaria prevalence to assess cost-effectiveness.
Takeaway
This study shows that using quick tests to check for malaria can save money, especially if we only test older kids and adults.
Methodology
The study assessed the cost-effectiveness of rapid diagnostic tests in two districts in southern Mozambique by comparing treatment costs under different scenarios of malaria prevalence.
Limitations
The study did not assess the costs of treating non-malaria febrile cases and relied on historical data for patient demographics.
Participant Demographics
Patients with clinically diagnosed malaria in two districts in southern Mozambique, primarily children aged 2-15 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website